Literature DB >> 16352713

Repression of beta-catenin function in malignant cells by nonsteroidal antiinflammatory drugs.

Desheng Lu1, Howard B Cottam, Maripat Corr, Dennis A Carson.   

Abstract

Activation of the Wnt/beta-catenin pathway promotes the development of several cancers and is an attractive target for chemopreventive and chemotherapeutic agents. Nonsteroidal antiinflammatory drugs (NSAIDs) have been reported to antagonize beta-catenin function, but their mechanism of action is not known. We demonstrate here that interference with beta-catenin function by NSAIDs does not correlate with cyclooxygenase (COX) inhibition. Instead, NSAID inhibition of beta-catenin requires the high level expression of peroxisome proliferator-activated receptor gamma (PPAR-gamma) and its co-receptor retinoid-X-receptor alpha (RXR-alpha). Immunoprecipitation experiments show that beta-catenin interacts with RXR-alpha and PPAR-gamma in some malignant cells. Repression of beta-catenin-dependent transcription by NSAIDs is thus indirect and depends on the coexpression of other nuclear receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352713      PMCID: PMC1317972          DOI: 10.1073/pnas.0509316102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

1.  Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.

Authors:  D Lu; Y Kiriyama; K Y Lee; V Giguère
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

2.  Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer.

Authors:  K Hovanes; T W Li; J E Munguia; T Truong; T Milovanovic; J Lawrence Marsh; R F Holcombe; M L Waterman
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

3.  Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells.

Authors:  Gillian Hawcroft; Mark D'Amico; Chris Albanese; Alexander F Markham; Richard G Pestell; Mark A Hull
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

4.  Inhibition of beta-catenin translocation in rodent colorectal tumors: a novel explanation for the protective effect of nonsteroidal antiinflammatory drugs in colorectal cancer.

Authors:  W A Brown; S A Skinner; D Vogiagis; P E O'Brien
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

5.  Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database.

Authors:  M J Langman; K K Cheng; E A Gilman; R J Lancashire
Journal:  BMJ       Date:  2000-06-17

6.  The NFAT-related protein NFATL1 (TonEBP/NFAT5) is induced upon T cell activation in a calcineurin-dependent manner.

Authors:  J Trama; Q Lu; R G Hawley; S N Ho
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

7.  Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

Authors:  M P Coghlan; A A Culbert; D A Cross; S L Corcoran; J W Yates; N J Pearce; O L Rausch; G J Murphy; P S Carter; L Roxbee Cox; D Mills; M J Brown; D Haigh; R W Ward; D G Smith; K J Murray; A D Reith; J C Holder
Journal:  Chem Biol       Date:  2000-10

8.  Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin.

Authors:  Susanne Dihlmann; Simone Klein; Magnus von Knebel Doeberitz Mv
Journal:  Mol Cancer Ther       Date:  2003-06       Impact factor: 6.261

9.  Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.

Authors:  H G Pálmer; J M González-Sancho; J Espada; M T Berciano; I Puig; J Baulida; M Quintanilla; A Cano; A G de Herreros; M Lafarga; A Muñoz
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

10.  Breast cancer and NSAID use: a meta-analysis.

Authors:  S A Khuder; A B Mutgi
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

View more
  33 in total

Review 1.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

Review 2.  Molecular basis of the potential of mesalazine to prevent colorectal cancer.

Authors:  Carmine Stolfi; Roberto Pellegrini; Eleonora Franze; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

3.  HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.

Authors:  Y Li; J H Bavarva; Z Wang; J Guo; C Qian; S N Thibodeau; E A Golemis; W Liu
Journal:  Oncogene       Date:  2011-02-14       Impact factor: 9.867

4.  Activation of β-catenin signaling is critical for doxorubicin-induced epithelial-mesenchymal transition in BGC-823 gastric cancer cell line.

Authors:  Rongfei Han; Jie Xiong; Ruijing Xiao; Ehtisham Altaf; Jin Wang; Yanping Liu; Hui Xu; Qianshan Ding; Qiuping Zhang
Journal:  Tumour Biol       Date:  2012-10-10

5.  PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer.

Authors:  A Belfiore; M Genua; R Malaguarnera
Journal:  PPAR Res       Date:  2009-07-07       Impact factor: 4.964

6.  Sulindac suppresses beta-catenin expression in human cancer cells.

Authors:  Anjia Han; Zibo Song; Chang Tong; Dong Hu; Xiuli Bi; Leonard H Augenlicht; Wancai Yang
Journal:  Eur J Pharmacol       Date:  2008-02-05       Impact factor: 4.432

7.  PPARgamma and Wnt/beta-Catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical/prognostic correlations.

Authors:  Ying Jiang; Lin Zou; Chunhui Zhang; Song He; Chun Cheng; Junfei Xu; Weiqi Lu; Yong Zhang; Hua Zhang; Donglin Wang; Aiguo Shen
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-03       Impact factor: 4.553

8.  Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma.

Authors:  Sen-Lin Xu; Dong-Zu Zeng; Wei-Guo Dong; Yan-Qing Ding; Jun Rao; Jiang-Jie Duan; Qing Liu; Jing Yang; Na Zhan; Ying Liu; Qi-Ping Hu; Xia Zhang; You-Hong Cui; Hsiang-Fu Kung; Shi-Cang Yu; Xiu-Wu Bian
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

9.  Spiperone enhances intracellular calcium level and inhibits the Wnt signaling pathway.

Authors:  Desheng Lu; Dennis A Carson
Journal:  BMC Pharmacol       Date:  2009-11-30

10.  Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.

Authors:  Desheng Lu; Jerry X Liu; Tomoyuki Endo; Haowen Zhou; Shiyin Yao; Karl Willert; Ingo G H Schmidt-Wolf; Thomas J Kipps; Dennis A Carson
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.